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Radical-Containing Particles Activate Dendritic Cells
and Enhance Th17 Inflammation in a Mouse Model
of Asthma
Pingli Wang1,2, Paul Thevenot1, Jordy Saravia1, Terry Ahlert1, and Stephania A. Cormier1
1

Department of Pharmacology and Experimental Therapeutics, Louisiana State University Health Sciences Center, New Orleans, Louisiana;
and 2Department of Respiratory Disease, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China

We identified a previously unrecognized component of airborne
particulate matter (PM) formed in combustion and thermal processes, namely, environmentally persistent free radicals (EPFRs). The
pulmonary health effects of EPFRs are currently unknown. In the
present study, we used a model EPFR-containing pollutant-particle
system referred to as MCP230. We evaluated the effects of MCP230
on the phenotype and function of bone marrow–derived dendritic
cells (BMDCs) in vitro and lung dendritic cells (DCs) in vivo, and the
subsequent T-cell response. We also investigated the adjuvant role
of MCP230 on airway inflammation in a mouse model of asthma.
MCP230 decreased intracellular reduced glutathione (GSH) and
the GSH/oxidized glutathione ratio in BMDCs, and up-regulated the
expression of costimulatory molecules CD80 and CD86 on DCs. The
maturation of DCs was blocked by inhibiting oxidative stress or
the uptake of MCP230. BMDCs exposed to MCP230 increased their
antigen-specific T-cell proliferation in vitro. In a model of asthma,
exposure to MCP230 exacerbated pulmonary inflammation, which
was attributed to the increase of neutrophils and macrophages but
not eosinophils. This result correlated with an increase in Th17 cells
and cytokines, compared with non–MCP230-treated but ovalbumin
(OVA)–challenged mice. The percentage of Th2 cells was comparable between OVA and OVA 1 MCP230 mice. Our data demonstrate
that combustion-generated, EPFR-containing PM directly induced
the maturation of DCs in an uptake-dependent and oxidative stress–
dependent manner. Furthermore, EPFR-containing PM induced a
Th17-biased phenotype in lung, accompanied by significant pulmonary neutrophilia. Exposure to EPFR-containing PM may constitute
an important and unrecognized risk factor in the exacerbation and
development of a severe asthma phenotype in humans.
Keywords: EPFR; dendritic cell; asthma; Th17; neutrophil

Epidemiological studies demonstrated that increased asthma
prevalence and exacerbation are closely associated with increased ambient air pollution (1–3). In particular, severe
asthma, which is usually not sensitive to glucocorticoid treatment, is mostly associated with exposure to air pollution (4).
Ambient air pollution is a complex mixture of particulates and
volatiles arising from various sources, with 40–70% of airborne
particulate matter (PM) attributed to emissions from various
types of combustion or thermal processes (5). A tremendous
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CLINICAL RELEVANCE
We identified a previously unrecognized component of
airborne particulate matter (PM) formed in combustion
and thermal processes, namely, environmentally persistent
free radicals (EPFRs). Exposure to EPFR-containing PM
results in Th17-specific pulmonary immune responses. These
data suggest that exposure to EPFR-containing PM may
constitute an important and unrecognized risk factor in the
exacerbation and development of a severe asthma phenotype in humans.

amount of attention has been paid to the contributions of
vehicular exhaust (such as diesel exhaust particulates; DEPs)
to the health effects associated with exposures to PM. In
contrast, comparatively little is known about the health effects
associated with exposure to particle-associated pollutant byproducts of combustion and the thermal treatment of hazardous
wastes and hazardous materials. Unfortunately, the complexity
and resulting nonuniformity of the composition of combustiongenerated particles, and particularly those generated from
treating hazardous substances, often limits attempts to determine the mechanism of their toxicity.
In the present study, we used a common by-product of waste
combustion, 2-monochlorophenol (2-MCP), associated with
a transition metal–containing fly ash. This pollutant-particle
system is a known source for the formation of polychlorinated
dibenzo-p-dioxins and dibenzofurans. When chlorinated phenols, such as 2-MCP, react with transition metal–laden particles
at slightly elevated temperatures, such as those occurring in
low-temperature thermal treatment units or the post-flame, cool
zone of high-temperature combustors, they form environmentally persistent free radicals (EPFRs). We are studying the
specific EPFR of 2-MCP that is formed by reaction with fly ash
containing Cu(II)O at 2308C (referred to as MCP230). Our
previous studies demonstrated that EPFRs such as MCP230
induced cellular oxidative stress and cytotoxicity (6). However,
the impact of exposure to MCP230 on the development and
exacerbation of asthma remains unknown.
Dendritic cells (DCs) are recognized as professional antigenpresenting cells (APCs), exhibiting a potent antigen-presenting
ability (7). DCs are crucial in regulating immune responses, and
play an important role in the induction of asthma. Several
studies showed that oxidative stress induces the maturation of
DCs. Mature DCs present antigens to naive T cells, and direct
the T-cell response. The role of EPFRs in inducing the
maturation and function of DCs is unknown. This study sought
to evaluate the effects of the EPFR-containing pollutantparticle system, MCP230, on the phenotype and function of
DCs and the subsequent T-cell response. In addition, we
investigated the adjuvant role of EPFRs on airway inflammation in a mouse model of asthma.
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MATERIALS AND METHODS
Mice
BALB/c mice (aged 6–8 weeks) and ovalbumin specific, T-cell receptor
(OVA-TCR) transgenic (Balb/C-Tg[DO11.1010]Loh/J) or DO11.10
mice were purchased from Harlan (Indianapolis, Indiana) and the
Jackson Laboratory (Bar Harbor, ME), respectively. Animal protocols
were prepared in accordance with the Guide for the Care and Use of
Laboratory Animals (8), and were approved by the Institutional
Animal Care and Use Committee at the Louisiana State University
Health Sciences Center.

Particles
EPFR-containing particles were produced as previously described (6).
The particle size was confirmed as 0.2 mm in diameter, according to
transmission electron microscopy and flow cytometry.

Generation and Treatment of Bone Marrow–Derived DCs
Our methods are described in the online supplement.

Quantification of Intracellular Reduced Glutathione and
Oxidized Glutathione of Bone Marrow–Derived DCs
Intracellular reduced glutathione (GSH) and oxidized glutathione
(GSSG) were quantified in bone marrow–derived DC (BMDC) lysates
according to the method of Rahman and colleagues (9), as described
in the online supplement.

Proliferation and Activation of T Cells by
MCP230-Pretreated BMDCs
Naive CD41 T cells were purified from the spleens of DO11.10 mice by
negative selection (Stemcell, Vancouver, British Columbia, Canada).
BMDCs were treated with 200 ng/ml ovalbumin peptide (OVA323–339;
Anaspec, Fremont, CA), along with MCP230 or vehicle (sham group),
in medium for 24 hours. DCs exposed to MCP230 or vehicle in the
presence or absence of alpha-phenyl N-tertiary-butyl nitrone (PBN) or
an uptake blocker were cocultured with purified CD41 T cells for
72 hours at a ratio of 1:5. CD41 T cells were labeled with 0.5 mM
carboxyfluorescein diacetate, succinimidyl ester (CFSE) (Invitrogen,
Carlsbad, CA). The dilution of CFSE and induction of CD69 were used
to determine the proliferation and activation, respectively, of CD41
T cells.

Asthma Model and Exposure to MCP230
Mice were divided into three groups: saline-exposed controls (sham),
ovalbumin-exposed (OVA), and OVA 1 MCP230. The OVA and
OVA 1 MCP230 mice were immunized intraperitoneally on Days 0 and
14 with 20 mg of OVA (Sigma-Aldrich, St. Louis, MO), emulsified in 100 ml
of Imject Alum (Pierce, Rockford, IL). On Days 24, 25, and 26, mice
were challenged with aerosolized OVA (1% in saline for 20 minutes).
Age-matched and sex-matched mice that had been sensitized and
challenged with saline at each time point were used as negative controls
(sham). OVA 1 MCP230 mice received 50 mg of MCP230 suspended in
sterile saline containing 0.02% Tween-80 by oropharyngeal aspiration.
Sham and OVA mice received the same volume of vehicle.

Figure 1. Exposure to the environmentally persistent free radical (EPFR)–
containing pollutant-particle system
MCP230 induced an innate immune response in lungs and the maturation of
pulmonary dendritic cells (DCs). (A) Mice
received MCP230 via oropharyngeal aspiration on Day 0. Bronchoalveolar lavage fluid (BALF) and lungs were isolated
for analyses of cellularity and chemokines
on Day 5. (B) Exposure to MCP230 increased the total numbers of leukocytes,
neutrophils, monocytes, and lymphocytes in BALF. (C) Representative micrographs demonstrate inflammatory cell
infiltrates in the perivascular and peribronchiolar regions (arrow). The mediastinal lymph node (MLN) was enlarged
upon instillation of MCP230. (D) Exposure to MCP230 increased concentrations of chemokine (C-X-C motif) ligand
1 (KC) and MCP–1 in BALF. (E) Exposure
to MCP230 increased the total number
of lung DCs (CD11c1MHCII1 cells).
(F and G) The mean fluorescence intensity (MFI) of CD86 (F) and CD80 (G) in
lung DCs was determined by flow cytometry. *P , 0.05. **P , 0.01. ***P , 0.001.
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Bronchoalveolar Lavage Fluid Cellularity and Measurement
of Cytokines
Our methods used are described in the online supplement.

Lung Histopathology
After bronchoalveolar lavage fluid (BALF) was acquired, lungs were
infused with HistoChoice (Amresco, Solon, OH) and isolated. Each
lung section was stained with hematoxylin and eosin.

Assessment of Pulmonary T-Cell Populations and Maturation
of DCs
A single-cell suspension of lung cells was prepared, using a standardized
protocol (10). Pulmonary T-cell populations and the maturation of DCs
were examined by flow cytometry (as detailed in the online supplement).

Expression of IL-17 in the Lung
The expression of IL-17A and IL-17F genes in lungs was analyzed by
real-time PCR (as detailed in the online supplement).

Statistical Analysis
Data were analyzed using InStat (GraphPad Software, version 3.0).
ANOVA was used to determine levels of differences between all
groups. Comparisons of all pairs were performed according to TukeyKramer tests. Data are presented as means 6 SEM. P , 0.05 was
considered statistically significant.

RESULTS
MCP230 Induces an Innate Immune Response, Recruitment
of Neutrophils, and Maturation of DCs in Mouse Lungs

To investigate whether exposure to MCP230 induced airway
inflammation, MCP230 was administered to mice via oropharyngeal aspiration (Figure 1A). Exposure to MCP230 increased
the total number of BALF leukocytes. This increase was
attributable to the recruitment of neutrophils, monocytes, and
lymphocytes (Figure 1B). Histopathology revealed inflammatory cell infiltration (Figure 1C) around vessels and bronchia.
This MCP230-induced cellular response correlated with increased concentrations of chemokine (C-X-C motif) ligand 1
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(KC) and monocyte chemoattractant protein 1 (MCP-1) in the
BALF (Figure 1D).
The total number of DCs in the lungs of mice exposed to
MCP230 was significantly increased over that of sham-treated
animals (Figure 1E). The increase in number of DCs was
accompanied by an increase in the maturation status of
pulmonary DCs, as evidenced by the increased expression of
costimulatory molecules CD86 and CD80 (Figures 1F and 1G).
Upon necropsy, we also found that the mediastinal lymph
nodes (MLNs) were enlarged in mice treated with MCP230
(Figure 1C).
MCP230-Induced Maturation of DCs Is Inhibited by
Treatment with Antioxidants or Uptake Blockers

To test whether exposure to MCP230 directly induced the
maturation of DCs, BMDCs were exposed to MCP230 particles. We found that exposure to MCP230 significantly upregulated CD86 and CD80 on CD11c1MHCII1 BMDCs
(Figure 2A). This increase was blocked after the addition of
the antioxidant PBN and the uptake blocker cocktail (Figure
2A). The uptake blocker cocktail reduced the uptake of
FITC–dextran, but failed to inhibit the maturation of BMDCs
in the presence of granulocyte-macrophage colony-stimulating
factor (GM-CSF), as evidenced by increased concentrations of
CD80 and CD86 (data not shown). These data indicate that
the uptake blocker cocktail inhibits the uptake of MCP230,
and blocks the maturation of BMDCs, by virtue of its ability to
inhibit macropinocytosis.
The ratio of cellular GSH/GSSG is a hallmark of oxidative
stress. To examine whether exposure to MCP230 induced
oxidative stress in BMDCs, the GSH/GSSG ratio of BMDCs
after stimulation with particles was tested. As shown in Figure
2B, a decrease in the GSH/GSSG ratio was evident in cells
exposed to MCP230. This decrease was reduced in cells
pretreated with 10 mM PBN for 1 hour. These data suggest
that the maturation of DCs after exposure to MCP230 is
dependent on particle uptake and the ability to induce oxidative stress.

Figure 2. Maturation of DCs
and oxidative stress after exposure to MCP230 in vitro. (A)
Expression of costimulatory molecules in CD11c1 MHCII1 bone
marrow–derived dendritic cells
(BMDCs). BMDCs were exposed
to vehicle (SHAM) or MCP230,
or pretreated with PBN or uptake blocker. Twenty-four hours
later, the expression of CD86
and CD80 in CD11c1 MHCII1
BMDCs was determined by flow
cytometry. Gray area in histogram represents isotype control.
(B) MCP230 regulates BMDC
glutathione homeostasis. After
exposure to MCP230 for 24
hours, DCs were collected and
lysed. Intracellular reduced glutathione (GSH) and oxidized
glutathione (GSSG) were measured in cell lysates. *P , 0.05.
#P , 0.05. ***P , 0.001.
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Figure 3. MCP230 alters the capacity of DCs to prime T cells. BMDCs were exposed to MCP230 or vehicle (SHAM) and ovalbumin peptide (OVA323–339),
with or without pretreatment with PBN or uptake blocker, for 24 hours. DCs were then cocultured with carboxyfluorescein diacetate, succinimidyl ester
(CFSE)-labeled naive DO11.10 TCR1CD41 T cells for 72 hours. Fluorescence intensities were measured by flow cytometry. (A) Representative histogram
of CFSE division profiles of CD41 T cells in each group. Data indicate percentages of dividing CD41 T cells (B) and CD691 activated CD41 T cells (C).
##P , 0.01. ###P , 0.001. ***P , 0.001.

MCP230-Pretreated DCs Induce CD41 T-Cell Proliferation
and Activation

Because MCP230 may directly induce the maturation of BMDCs,
we further examined the ability of MCP230-pretreated BMDCs to
induce the proliferation and activation of CD41 T cells. In this
experiment, OVA323–339 peptide and OVA-TCR transgenic mice
(DO11.10) were used. As shown in Figure 3, BMDCs co-exposed
to MCP230 and OVA323–339 induced significant proliferation
(Figures 3A and 3B) and activation (Figure 3C) of CD41 T cells
from DO11.10 mice. The ability of MCP230 to induce the
activation and proliferation of T cells was inhibited by PBN or
the uptake blocker cocktail (Figure 3).
MCP230 Enhances Pulmonary Inflammation in a Mouse
Model of Asthma by Inducing Maturation of DCs

Because our in vivo and in vitro studies demonstrated that
exposure to MCP230 was capable of inducing the maturation
of DCs and enhancing the capacity of DCs to stimulate the
proliferation and activation of T cells, we were interested in the
role of MCP230 exposure in exacerbating asthma. A mouse
model of asthma was established by OVA sensitization and
challenge. MCP230 was instilled into the bronchi of mice 24
hours before their first OVA challenge (Figure 4A). Mice treated
with MCP230 recruited more inflammatory cells to the lung
compared with sham mice exposed only to vehicle or OVA mice,
as evidenced by the total number of cells recruited to the BALF
(Figure 4B) and peribronchial regions (Figure 4C). Differential
cell counts of the BALF demonstrated significant elevations in
the numbers of neutrophils and macrophages, but not eosinophils
(Figure 4B). Upon necropsy, we observed a tremendous increase
in the size of MLNs from mice of the OVA 1 MCP230 group,
compared with that of OVA mice (Figure 4D).
The status of CD11c1MHCII1 DC maturation was also
examined. Compared with sham mice, the number of DCs in

the lungs of OVA-sensitized and OVA-challenged mice was
significantly higher (Figure 4E). Total numbers of DCs did not
differ between OVA 1 MCP230 and OVA mice. The expression of the costimulatory molecules CD86 and CD80 had
increased (Figures 4F and 4G) in both OVA and OVA 1
MCP230 mice. Treatment with MCP230 induced a significantly
greater expression of both CD86 and CD80, compared with
OVA alone (Figures 4F and 4G).
MCP230 Increases IL-17–Producing T Cells in Lung Tissues,
but Not IL-4–Producing T Cells

To examine the role of MCP230 in the differentiation of
pulmonary T cells, pulmonary T-cell subpopulations were measured using intracellular cytokine staining. The results were gated
on CD41 or CD81 populations. Sensitization or challenge with
OVA initiated strong Th2 and Tc2 immune responses and weak
Th17 and Tc17 responses, whereas the IFN-g response was not
statistically different from that in sham-treated mice (Figures 5A
and 5B). The exposure of ‘‘asthmatic mice’’ to MCP230 resulted
in a significant increase in the number of T cells producing IL-17,
compared with non–MCP230-treated but OVA-challenged mice
(Figures 5A and 5B). The elevated concentration of IL-17A and
IL-17F mRNA in the lungs of the OVA 1 MCP230 mice
confirmed this phenomenon (Figures 5C and 5D). The percentage of T cells producing IL-4 was comparable between the OVA
and OVA 1 MCP230 mice.
The cytokines in BALF were also analyzed. In total, 13
cytokines and chemokines were measured, and 11 (IL-4, IL-5,
IL-1b, IL-10, IL-13, IFN-g, IL-12p40, TNF-a, KC, MCP-1, and
macrophage inflammatory protein 2 [MIP-2]) were detectable
in BALF. Higher levels of IL-4, IL-5, IL-13, and KC (Table 1)
were detected in the BALF of OVA-sensitized/challenged mice,
compared with sham-treated mice. The exposure of asthmatic
mice to MCP230 resulted in a further increase in the concen-
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Figure 4. MCP230 enhanced
pulmonary inflammation in
a mouse model of asthma by
inducing the maturation of
DCs. (A) Schematic of the protocol used to induce allergic
inflammation (i.e., mouse
model of asthma). OVA complexed to Imject Alum was administered intraperitoneally on
Protocol Days 0 and 14. Mice
were then challenged with
aerosolized OVA on Protocol
Days 24, 25, and 26. The
OVA 1 MCP230 group was
exposed to MCP230 on Protocol Day 23. Sham control mice
were exposed to saline and vehicle. (B) BALF was acquired,
and cells were differentiated
and counted. (C ) Representative micrographs of the lungs
of mice exposed to sham, OVA,
or OVA 1 MCP230 (hematoxylin and eosin stain). (D) MLNs
from OVA 1 MCP230 mice
were larger than those of OVA
mice. (E–G) Lung cells were
isolated and stained with fluorescently labeled antibodies to
determine the numbers and
maturation status of DCs. Numbers of pulmonary DCs (E) and
the MFIs of CD86 (F) and CD80
(G) in lung DCs were determined by flow cytometry.
#P , 0.05. ##P , 0.01. **P ,
0.01. ***P , 0.001.

trations of IL-13, KC, and MCP-1 over those of OVA mice. The
concentrations of IL-10 and IFN-g in BALF were comparable
in all three groups.

DISCUSSION
This study explored the effects of a recently identified component of airborne PM formed during processes of combustion,
namely, the EPFRs. The EPFR-containing ultrafine particle used
in this study was created by combusting 1,2-monochlorophenol in
the presence of a metal catalyst and silica substrate (i.e., MCP230).
In particular, this study explored the role of MCP230 in altering
pulmonary immunologic homeostasis in normal mice or mice

with allergic airway inflammation (i.e., mice with asthma). Our
data demonstrated that MCP230 directly induced the maturation of pulmonary DCs and enhanced OVA-induced allergic
airway inflammation. This did not correlate with eosinophilic
inflammation, as expected of a traditional model of OVAinduced asthma, but rather with pulmonary neutrophilia. The
observed neutrophilia appeared to be directly related to
MCP230 exposure. In addition, MCP230 enhanced the Th17
immune response observed after OVA sensitization and challenge. Neutrophilic inflammation and Th17 immune responses
are predominantly associated with persistent and difficultto-control asthma (i.e., with poor responses to corticosteroids)
(11–16).
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Figure 5. MCP230 influences pulmonary T-cell
responses in a mouse model of asthma. (A and B)
Lung cells were isolated, stimulated with phorbol
myristate acetate and ionomycin, and stained with
surface antibodies (CD4 and CD8) and intracellular
antibodies (IFN-g, IL-4, and IL-17A). Subsets of
T cells were then quantified using flow cytometry.
(C and D) The expression of IL-17A and IL-17F
genes in whole-lung homogenates was tested by
real-time PCR. #P , 0.05. *P , 0.05. **P , 0.01.
***P , 0.001.

Exposure to MCP230 induced the maturation of lung DCs
in vivo, and stimulated the expression of the costimulatory
molecules CD80 and CD86 in BMDCs in vitro, suggesting that
MCP230 directly stimulates the maturation of DCs. Comparable effects on the maturation of DCs were observed after
exposure of human blood-derived monocytes or BMDCs to
freshly collected air pollution particles and ultrafine carbon
black particles (17–19).
The mechanism by which ambient PM induces the maturation of DCs remains unclear. However, it seems logical to
assume that particle uptake, by either specialized phagocytic or
endocytic mechanisms, is necessary to promote the maturation
of DCs. Indeed, our data demonstrate that particle uptake is
necessary for increasing the expression of the costimulatory
molecules CD86 and CD80.
Oxidative stress is also thought to play an important role in
inducing the maturation of DCs (19–21). GSH is an important
tripeptidethiol antioxidant, and its intracellular concentration
and a decreased GSH/GSSG ratio are indicators of oxidative
stress (9). In this study, exposure to MCP230 induced oxidative
stress in BMDCs, as evidenced by decreased GSH and GSH/
GSSG ratio. The antioxidant PBN was able to decrease the
MCP230-induced oxidative stress of BMDCs, and also inhibited
their maturation (i.e., decreased the expression of CD86 and
CD80). Because amorphous silica particles, which do not
contain an EPFR, failed to induce the maturation of BMDCs,
these data cumulatively suggest that the pro-oxidant property of
MCP230 is responsible for inducing the maturation of DCs.
We further examined the effects of pulmonary exposure to
MCP230 on pulmonary DCs in the presence of an antigen
(OVA). As expected, MCP230 enhanced the expression of
costimulatory molecules on DCs in the presence of the antigen.
Furthermore, these more mature DCs were capable of inducing
stronger CD41 T-cell proliferation and activation responses.
These data are compatible with the enhanced inflammation in
the lung and enlarged MLNs in the MCP230-exposed and
OVA-challenged mice. These findings suggest that MCP230
amplifies the functional activation of DCs by inducing the
elevated expression of costimulatory molecules, thus exerting

a durable effect on the antigen-presenting ability of DCs. In
mice with asthma, MCP230 appeared to synergize with allergen,
to exacerbate pulmonary pathophysiology.
In this study, exposure to MCP230 elicited an enhanced
Th17 immune response in a mouse model of asthma. This result
is contrary to previous reports of Th responses after many other
exposures, including PM and DEPs (22–24). Many studies with
DEPs, for example, demonstrated that the generation of
oxidative stress by DEPs favors a Th2 skewing of the immune
response, while suppressing Th1 differentiation (24–27). This
Th2 skew correlated with significant eosinophilic inflammation
in the lung and an OVA–IgG1 response in already sensitized
animals (28). In this study, the Th2 immune responses of OVA 1

TABLE 1. CYTOKINES AND CHEMOKINES IN BRONCOALVEOLAR
LAVAGE FLUID (pg/ml)
Sham Group
IFN-g
IL-4
IL-5
IL-1b
IL-13
IL-10
IL-12p40
TNF-a
KC
MCP-1
MIP-2

6.50
3.13
7.90
1.47
4.52
6.38
5.56
4.26
29.78
3.04
23.19

6
6
6
6
6
6
6
6
6
6
6

1.38
1.07
0.42
0.42
0.83
1.07
1.18
0.18
1.99
0.43
5.22

OVA Group
6.66 6 3.28
13.64 6 1.62†
57.43 6 11.31*
4.02 6 1.36
27.13 6 4.51†
8.40 6 1.99
7.90 6 2.23
4.25 6 0.28
193.30 6 17.84‡
5.34 6 1.49
18.35 6 3.50

OVA 1 MCP230 Group
9.82
18.53
63.24
6.07
46.90
12.17
14.62
5.20
270.45
9.65
31.59

6 0.97
6 4.16†
6 9.32†
6 0.86
6 7.59‡,x
6 2.87
6 3.45
6 0.54
6 29.67‡,x
6 1.52*
6 6.33

Definition of abbreviations: OVA, ovalbumin; MCP230, EPFR of 2-MCP that is
formed by reaction with Cu(II)O containing fly-ash at 2308C; KC 5 chemokine
(C-X-C motif) ligand 1; MCP-1 5 monocyte chemoattractant protein 1; MIP-2 5
macrophage inflammatory protein 2.
Cytokines and chemokines in BALF were examined using a multiplex mouse
cytokine/chemokine assay kit. Results are expressed as means 6 SEM (n 5 7–8
mice/group).
* P , 0.05.
†
P , 0.01.
‡
P , 0.001 versus sham group.
x
P , 0.05 versus OVA group.
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MCP230–exposed animals were not statistically different from
those of OVA–sensitized or OVA–challenged animals, and the
Th17 responses were significantly greater. This result is compatible with the demonstration in our model of increased IL17A gene expression in the lung and increased neutrophil
concentrations in the BALF of mice exposed to MCP230.
These differences in immune responses are most likely
related to the differences in chemical composition of various
PMs and DEPs and MCP230. For example, carbonaceous
particles and a quinone in DEPs were shown to promote Th1
immune responses, whereas chemical components extracted
with benzene–ethanol initiated Th2 responses (22, 23). Th17
and associated cytokines were implicated in the development
and promotion of steroid-resistant asthma and airway inflammation and hyperresponsiveness in humans and mice (12, 16).
The mechanism by which MCP230 induces Th17 but not Th2
immune responses is not clear. But in total, our data suggest
that exposure to MCP230 may be a significant and unrealized
risk factor in the development of steroid-resistant asthma.
In conclusion, our data demonstrate that EPFR-containing
PM formed during processes of combustion directly induced the
maturation of DCs in an uptake-dependent and oxidative
stress–dependent manner. Alterations in the maturation of
DCs were accompanied by alterations in Th cell subsets in the
lung. The local Th17-biased phenotype (increased Th17 cells
and cytokines) was accompanied by significant pulmonary
neutrophilia. Pulmonary neutrophilic inflammation, the presence of Th17 cytokines, and elevated numbers of Th17 cells in
the lung are reminiscent of severe, steroid-insensitive asthma in
humans. Thus, exposure to EPFR-containing PM may constitute an important and unrecognized risk factor in the exacerbation and development of a severe and steroid-resistant
asthma phenotype in humans.
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